KPT-330 has antitumour activity against non-small cell lung cancer

被引:0
作者
H Sun
N Hattori
W Chien
Q Sun
M Sudo
G L E-Ling
L Ding
S L Lim
S Shacham
M Kauffman
T Nakamaki
H P Koeffler
机构
[1] Cedars-Sinai Medical Center,Department of Hematology and Oncology
[2] Cancer Science Institute of Singapore,Division of Hematology, Department of Medicine
[3] National Cancer Institute,undefined
[4] NUS,undefined
[5] Karyopharm Therapeutics,undefined
[6] Showa University School of Medicine,undefined
来源
British Journal of Cancer | 2014年 / 111卷
关键词
CRM1; SINE; NSCLC; p53; p73;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:281 / 291
页数:10
相关论文
共 360 条
  • [1] Al-Bahlani S(2011)P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism Oncogene 30 4219-4230
  • [2] Fraser M(2006)BCR-ABL nuclear entrapment kills human CML cells: Blood 107 1591-1598
  • [3] Wong AY(2013) study on 35 patients with the combination of imatinib mesylate and leptomycin B Gastroenterology 144 447-456
  • [4] Sayan BS(2013)Selective inhibitors of nuclear export block pancreatic cancer cell proliferation and reduce tumor growth in mice Haematologica 98 1098-1106
  • [5] Bergeron R(2010)Selective inhibitors of nuclear export for the treatment of non-Hodgkin's lymphomas Curr Drug Targets 11 667-681
  • [6] Melino G(2013)Targeting the p53-family in cancer and chemosensitivity: triple threat Br J Haematol 161 117-127
  • [7] Tsang BK(2013)KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia Leukemia 27 66-74
  • [8] Aloisi A(1997)Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells Cell 90 1051-1060
  • [9] Di Gregorio S(1998)CRM1 is an export receptor for leucine-rich nuclear export signals Mol Cell Biol 18 7288-7293
  • [10] Stagno F(1997)Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6 Nature 390 308-311